ArticlePediatric cardiology2026
Transcatheter Versus Surgical Correction of Superior Sinus Venosus Defects: Comparison of the Outcomes and Late Complications.
Article in Pediatric cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Structural Heart Interventions in Women with Congenital Heart Disease.Current cardiology reports · 2026Review
- Conservative management of iatrogenic pulmonary vein obstruction following transcatheter sinus venosus ASD repair: a case insight and literature review.BMC cardiovascular disorders · 2026Review
- Incidence and Predictors of Stent Thrombosis Following Transcatheter Sinus Venosus Defect Closure.Pediatric cardiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Transcatheter correction (TC) of sinus venosus defects (SVD) is an emerging alternative to surgical correction (SC). Superior vena caval (SVC) or right upper pulmonary vein (RUPV) stenosis and sick sinus syndrome are complications of SC. This retrospective study analyzed the outcomes of SC and TC in the last 14 years. TC was considered in children only when their parents refused surgery and accepted the follow-up imaging protocol. Follow-up Transesophageal echocardiography (TEE), computed tomography (CT), or magnetic resonance (MR) were performed after all TC to identify residual shunt, venous obstruction, and stent thrombosis. Follow-up after SC was limited to transthoracic echocardiography, unless patients consented for TEE or CT. The study compared 148 SC and 127 TC between 2011 and 2024. While SC group were significantly younger, TC groups were more symptomatic and more often had pulmonary hypertension. Comorbidities occurred in 14% of SC and 26% of TC. Pre-procedural CT/MR performed in 73.2% of TC identified additional pulmonary veins in 23.6%; advanced imaging was rarely performed before SC and identified additional veins in 5.3% only. Surgical and bypass times in SC far exceeded procedural and fluoroscopic times in TC. Hospital and intensive care stay were significantly lower in TC. Three procedural failures in TC (2.4%) due to stent embolization occurred in early learning curve. Acute complications in 18.1% of TC and 9.1% of SC were successfully managed. Late complications occurred in 23.8% of SC (SVC or RUPV stenosis, residual shunt, and sinus nodal dysfunction) and 12% of TC (stent thrombosis or residual shunt). Reinterventions were required in 4.6% after SC and 1.6% after TC. SC and TC had comparable outcomes, complications, and reinterventions. TC is an attractive option in adults especially with comorbidities and pulmonary hypertension. Continued surveillance is mandatory to determine the long-term outcomes.
Indexed as
Identifiers
40751838What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.